Task: Answer the MCQ question.
Question: Which drug exhibits a 4.225% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COCCN(C(=O)COC(=O)Cc1coc2cc3c(cc12)CCC3)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
[b] CCCc1cc(C(=O)Nc2nnc(C)s2)cs1
Answer: b. CCCc1cc(C(=O)Nc2nnc(C)s2)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(C(=O)Nc2nnc(C)s2)cs1
CCCc1cc(C(=O)Nc2nnc(C)s2)cs1
N-(5-methyl-1,3,4-thiadiazol-2-yl)-5-propylthiophene-3-carboxamide